Cancer Biology & Genetics Program
The Christine Mayr Lab
My laboratory studies how mRNA elements that do not encode amino acids contribute to the regulation of biological complexity. We examine how 3′ untranslated regions (3′UTRs) regulate protein functions without affecting protein abundance. We also investigate the role of mRNAs as cytoplasmic organizers that enable subcellular compartmentalization required for the implementation of protein functions.
Christine Mayr, MD, PhD
- Molecular and cell biologist Christine Mayr studies how 3′UTRs regulate protein functions and how mRNAs contribute to cytoplasmic organization.
- MD, Free University Berlin
- PhD, Humboldt University Berlin
- Luise and Allston Boyer Young Investigator Award for Basic Research (2019)
- NIH Director’s Pioneer Award (2016)
- Pershing Square Sohn Prize for Young Investigators in Cancer Research (2015)
- Damon Runyon-Rachleff Innovation Award, Damon Runyon Cancer Research Foundation (2012)
To learn more about available postdoctoral opportunities, please visit our Career Center
Get in Touch
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Christine Mayr discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.